2m 2m 2m 2m 2m 2m 2m
TRAWS PHARMA (TRAW)
NASDAQ
$1.44-$0.006 (-0.41%)
Price as of Jun 03, 2026 7:50 PM EDT- $22.1MMarket Cap
- -24.06%1-Year Change
- BiotechnologyIndustry
TRAWS PHARMA (TRAW)
$1.44-$0.006 (-0.41%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.8M +1,134.51% | 226,000 0.00% | 226,000 0.00% | 226,000 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.8M +1,134.51% | 226,000 0.00% | 226,000 0.00% | 226,000 0.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -12.1M -5.48% | -12.8M +12.40% | -11.4M +0.21% | -11.4M +56.31% | |
Depreciation and Amortization Expense | 61,000 +408.33% | 12,000 -25.00% | 16,000 +14.29% | 14,000 0.00% | |
Total Operating Expenses | 20.7M -85.51% | 142.6M +594.80% | 20.5M +3.38% | 19.9M +18.72% | |
Operating Profit | -17.9M -87.45% | -142.4M +601.42% | -20.3M +3.42% | -19.6M +18.98% | |
Interest Income | 455,000 -10.78% | 510,000 -63.34% | 1.4M +113.67% | 651,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 455,000 -10.78% | 510,000 -63.34% | 1.4M +113.67% | 651,000 N/A | |
Total Nonoperating Income and Expense | 478,000 +65.40% | 289,000 -78.59% | 1.4M +103.62% | 663,000 +5,425.00% | |
Income before Taxes | 6.9M +112.56% | -54.7M +169.36% | -20.3M +3.42% | -19.6M +21.43% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | 9.2M +105.51% | -166.5M +778.84% | -18.9M -0.08% | -19.0M +17.33% | |
Net Income from Continuing Operations Applicable to Common | 6.9M +112.56% | -54.7M +188.55% | -18.9M -0.08% | -19.0M +17.33% | |
Basic EPS and Net Income | 0.83 +102.36% | -35.21 +3,812.22% | -0.90 -1.10% | -0.91 -5.21% | |
Diluted EPS and Net Income | 0.82 +102.33% | -35.21 +3,812.22% | -0.90 -1.10% | -0.91 -5.21% | |
Basic Weighted Average Shares | 8.2M +429.93% | 1.6M -92.60% | 21.0M +0.39% | 20.9M +24.22% | |
Diluted Weighted Average Shares | 8.4M +439.48% | 1.6M -92.60% | 21.0M +0.39% | 20.9M +24.22% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.8M -82.10% | 21.3M +2.48% | 20.8M -46.28% | 38.8M -29.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.8M -82.10% | 21.3M +2.48% | 20.8M -46.28% | 38.8M -29.62% | |
Total Current Assets | 8.0M -68.02% | 25.0M +10.11% | 22.7M -42.41% | 39.3M -29.01% | |
Accumulated Depreciation | 77,000 +4.05% | 74,000 +19.35% | 62,000 +34.78% | 46,000 +43.75% | |
Property and Plant and Equipment and Net | 7,000 -30.00% | 10,000 -54.55% | 22,000 -8.33% | 24,000 -36.84% | |
Total Long-Term Assets | 104,000 +10,300.00% | 1,000 0.00% | 1,000 0.00% | 1,000 -90.00% | |
Total Assets | 10.6M -57.47% | 25.0M +10.05% | 22.7M -42.39% | 39.4M -29.03% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.1M -3.36% | 11.5M +25.09% | 9.2M +14.59% | 8.0M +31.58% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2.7M -94.09% | 45.1M +1,514.44% | 2.8M -7.49% | 3.0M -15.35% | |
Total Liabilities | 11.2M -80.13% | 56.6M +371.17% | 12.0M +8.57% | 11.1M +18.22% | |
Retained Earnings | -640.0M -1.41% | -649.2M +34.50% | -482.6M +4.09% | -463.7M +4.26% | |
Total Stockholders Equity | -629,000 -98.01% | -31.6M -396.38% | 10.7M -62.30% | 28.3M -38.62% | |
Total Shares Outstanding | 9.1M +148.38% | 3.7M -82.62% | 21.0M +0.37% | 20.9M +0.15% | |
Cash Flow | |||||
Cash from Operating Activities | -18.2M -38.96% | -29.8M +66.14% | -17.9M +10.05% | -16.3M -16.39% | |
Capital Expenditures | 2.6M +18,364.29% | 14,000 0.00% | 14,000 N/A | N/A N/A | |
Cash from Investing Activities | -2.6M -29.14% | -3.6M +25,957.14% | -14,000 N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 3.2M -90.57% | 34.0M N/A | N/A N/A | 55.6M 0.00% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -640.68% -98.98% | -62,997.35% +601.42% | -8,981.42% +3.42% | -8,684.51% +18.98% | |
Return on Assets | 51.55% +107.37% | -699.02% +1,044.64% | -61.07% +52.72% | -39.99% -6.65% | |
Return on Equity | -56.85% -103.58% | 1,589.11% +1,734.61% | -97.22% +90.78% | -50.96% -17.56% | |
Revenue Growth | 1,134.51% N/A | 0.00% N/A | 0.00% N/A | 0.00% +100.00% | |
Current Ratio | 0.72 -66.91% | 2.16 -11.97% | 2.46 -49.74% | 4.89 -46.05% | |
Cash Ratio | 0.34 -81.48% | 1.85 -18.07% | 2.26 -53.12% | 4.82 -46.51% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow